Cargando…
MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma
BACKGROUND: Therapeutic microRNAs (miRNAs) delivery holds a lot of promise for treating human malignancies. So, this study was carried out to examine the potential of miR-122 mimic and/or miR-221 inhibitor as an innovative therapeutic strategy for HCC in an animal model. METHODOLOGY: Mice were categ...
Autores principales: | Hassan, Marwa, Elzallat, Mohamed, Aboushousha, Tarek, Elhusseny, Yasmine, El-Ahwany, Eman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713283/ https://www.ncbi.nlm.nih.gov/pubmed/36474748 http://dx.doi.org/10.1016/j.ncrna.2022.11.005 |
Ejemplares similares
-
MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients
por: El-Ahwany, Eman G. E., et al.
Publicado: (2019) -
Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022) -
Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC)
por: Shehab-Eldeen, Somaia, et al.
Publicado: (2019) -
Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2014) -
MicroRNA-199: A Potential Therapeutic Tool for Hepatocellular Carcinoma in an Experimental Model
por: Atta, Shimaa, et al.
Publicado: (2021)